{"news_desk": "Business", "print_page": "2", "section_name": "Business Day", "subsection_name": null, "byline": {"contributor": "", "original": "By THE ASSOCIATED PRESS", "person": [], "organization": "THE ASSOCIATED PRESS"}, "abstract": "Food and Drug Administration warns two hepatitis C drugs from AbbVie can cause life-threatening liver injury in patients with advanced forms of disease.", "type_of_material": "Brief", "word_count": "165", "lead_paragraph": "Federal health officials are warning doctors and patients that two hepatitis C drugs from AbbVie can cause life-threatening liver injury in patients with advanced forms of the disease.", "pub_date": "2015-10-23T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "2 Abbvie Hepatitis C Drugs Can Cause Injury, F.D.A. Warns ", "content_kicker": "Business Briefing", "print_headline": "2 Abbvie Hepatitis C Drugs Can Cause Injury, F.D.A. Warns "}, "snippet": "Federal health officials are warning doctors and patients that two hepatitis C drugs from AbbVie can cause life-threatening liver injury in patients with advanced forms of the disease.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/10/23/business/2-abbvie-hepatitis-c-drugs-can-cause-injury-fda-warns.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "AbbVie Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Hepatitis", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "4", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "5", "is_major": "Y", "value": "Liver", "name": "subject"}], "blog": [], "_id": "5629666838f0d843c6275e12", "source": "The New York Times"}